<![CDATA[Latest Publisher Reports]]> http://www.researchmoz.com Wed, 18 Jul 2012 12:20:54 +0000 en hourly 1 http://wordpress.org/?v=3.3.1Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwidehttp://www.researchmoz.com/risk-sharing-and-other-forms-of-managed-entry-agreements-for-medicines-worldwide-report.htmlhttp://www.researchmoz.com/risk-sharing-and-other-forms-of-managed-entry-agreements-for-medicines-worldwide-report.html#commentsFri, 01 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/risk-sharing-and-other-forms-of-managed-entry-agreements-for-medicines-worldwide-report.html
Original Post Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
source Researchmoz]]>
Original Post Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
source Researchmoz]]>http://www.researchmoz.com/risk-sharing-and-other-forms-of-managed-entry-agreements-for-medicines-worldwide-report.html/feed0 Pharmaceutical Pricing & Distribution in Japan, 2012 Updatehttp://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2012-update-report.htmlhttp://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2012-update-report.html#commentsWed, 13 Jun 2012 00:00:00 -0500adminhttp://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2012-update-report.html
Original Post Pharmaceutical Pricing & Distribution in Japan, 2012 Update
source Researchmoz]]>
Original Post Pharmaceutical Pricing & Distribution in Japan, 2012 Update
source Researchmoz]]>http://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2012-update-report.html/feed0 Biosimilars: Current Situation & Future Prospects, Worldwidehttp://www.researchmoz.com/biosimilars-current-situation-and-future-prospects-worldwide-report.htmlhttp://www.researchmoz.com/biosimilars-current-situation-and-future-prospects-worldwide-report.html#commentsThu, 01 Mar 2012 00:00:00 -0600adminhttp://www.researchmoz.com/biosimilars-current-situation-and-future-prospects-worldwide-report.html
Original Post Biosimilars: Current Situation & Future Prospects, Worldwide
source Researchmoz]]>
Original Post Biosimilars: Current Situation & Future Prospects, Worldwide
source Researchmoz]]>http://www.researchmoz.com/biosimilars-current-situation-and-future-prospects-worldwide-report.html/feed0 Pharmaceutical Pricing & Distribution in Japan, 2010 Updatehttp://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2010-update-report.htmlhttp://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2010-update-report.html#commentsSat, 01 Oct 2011 00:00:00 -0500adminhttp://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2010-update-report.html
Original Post Pharmaceutical Pricing & Distribution in Japan, 2010 Update
source Researchmoz]]>
Original Post Pharmaceutical Pricing & Distribution in Japan, 2010 Update
source Researchmoz]]>http://www.researchmoz.com/pharmaceutical-pricing-and-distribution-in-japan-2010-update-report.html/feed0 Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Editionhttp://www.researchmoz.com/orphan-drugs-in-europe-pricing-reimbursement-funding-and-market-access-issues-2011-edition-report.htmlhttp://www.researchmoz.com/orphan-drugs-in-europe-pricing-reimbursement-funding-and-market-access-issues-2011-edition-report.html#commentsWed, 01 Jun 2011 00:00:00 -0500adminhttp://www.researchmoz.com/orphan-drugs-in-europe-pricing-reimbursement-funding-and-market-access-issues-2011-edition-report.html
Original Post Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
source Researchmoz]]>
Original Post Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
source Researchmoz]]>http://www.researchmoz.com/orphan-drugs-in-europe-pricing-reimbursement-funding-and-market-access-issues-2011-edition-report.html/feed0 Market Access Korea: Breaking into the Developed World's Fastest Growing Pharmaceutical Markethttp://www.researchmoz.com/market-access-korea-breaking-into-the-developed-worlds-fastest-growing-pharmaceutical-market-report.htmlhttp://www.researchmoz.com/market-access-korea-breaking-into-the-developed-worlds-fastest-growing-pharmaceutical-market-report.html#commentsMon, 01 Nov 2010 00:00:00 -0500adminhttp://www.researchmoz.com/market-access-korea-breaking-into-the-developed-worlds-fastest-growing-pharmaceutical-market-report.html
Original Post Market Access Korea: Breaking into the Developed World's Fastest Growing Pharmaceutical Market
source Researchmoz]]>
Original Post Market Access Korea: Breaking into the Developed World's Fastest Growing Pharmaceutical Market
source Researchmoz]]>http://www.researchmoz.com/market-access-korea-breaking-into-the-developed-worlds-fastest-growing-pharmaceutical-market-report.html/feed0 Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Accesshttp://www.researchmoz.com/orphan-drugs-in-asia-pacific-from-designation-to-pricing-funding-and-market-access-report.htmlhttp://www.researchmoz.com/orphan-drugs-in-asia-pacific-from-designation-to-pricing-funding-and-market-access-report.html#commentsMon, 01 Feb 2010 00:00:00 -0600adminhttp://www.researchmoz.com/orphan-drugs-in-asia-pacific-from-designation-to-pricing-funding-and-market-access-report.html
Original Post Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
source Researchmoz]]>
Original Post Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
source Researchmoz]]>http://www.researchmoz.com/orphan-drugs-in-asia-pacific-from-designation-to-pricing-funding-and-market-access-report.html/feed0